Elarofiban (RWJ-53308) is a nonpeptide, orally active antagonist for fibrinogen receptor α IIb β 3 (GPIIb/IIIa) , with an IC 50 of 0.15 nM. Elarofiban has the potential for platelet mediated thrombotic disorders research.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Integrin
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。